CLDN6 and testicular germ cell tumor: Although CLDN18.2 and CLDN6 are recognized as promising tumor-associated antigen (TAA) genes, CLDN6 is highly expressed in ovary and testicular germ cell tumors, and CLDN18.2 is highly expressed in pancreatic and stomach tumors (Fig. S9).